Cavalry Fund I LP 13D and 13G filings for Biodexa Pharmaceuticals Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-07 4:51 pm Sale | 2024-09-30 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Cavalry Fund I LP | 0 0.000% | -9 (Position Closed) | Filing |
| 2024-02-13 4:33 pm Unchanged | 2023-12-31 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Cavalry Fund I LP | 9 9.900% | 0 (Unchanged) | Filing |
| 2023-12-28 4:30 pm Purchase | 2023-12-21 | 13G | BIODEXA PHARMACEUTICALS INC SP BDRX | Cavalry Fund I LP | 9 9.900% | 9 (New Position) | Filing |